DD
Devi Dayal
About Devi Dayal
Data last updated:
Devi Dayal is a Director at Supernova Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Supernova Pharmaceuticals Private Limited reported revenue of ₹3.9 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supernova Pharmaceuticals Private Limited U74999DL2016PTC304616 | Director | 24 Nov 2018 | 2016 | ₹3.9 Lakh (FY 2019) | Active |
Board colleagues of Devi Dayal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amardeep Kaur | 08048549 | Supernova Pharmaceuticals Private Limited | Director |
| Mohan Singh Rawat | 08278081 | Supernova Pharmaceuticals Private Limited | Director |
| Om Prakash Tanwar | 08812901 | Supernova Pharmaceuticals Private Limited | Director |
| Rahul Malik | 03609363 | Supernova Pharmaceuticals Private Limited | Director |
| Rukmani | 08278113 | Supernova Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devi Dayal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devi Dayal
Devi Dayal currently holds 1 directorship: Supernova Pharmaceuticals Private Limited (Director, since 24 Nov 2018, revenue ₹3.9 Lakh (FY 2019)).
Devi Dayal was first appointed on 24 Nov 2018 as Director at Supernova Pharmaceuticals Private Limited.
The current boards of Devi Dayal's companies include Amardeep Kaur (Supernova Pharmaceuticals Private Limited), Mohan Singh Rawat (Supernova Pharmaceuticals Private Limited), Om Prakash Tanwar (Supernova Pharmaceuticals Private Limited), Rahul Malik (Supernova Pharmaceuticals Private Limited), Rukmani (Supernova Pharmaceuticals Private Limited).